Gleamer - www.gleamer.ai

Gleamer is a French medical imaging analysis platform that utilizes artificial intelligence technology to assist radiologists in diagnosing and analyzing medical images. Here is a detailed introduction:

Company Profile: Founded in 2017, Gleamer is headquartered in Saint Mande, France. It has 103 employees and is a privately held company backed by venture capital.

Core Technology: The platform's AI tools employ deep learning and image recognition technology to improve the speed and accuracy of detecting fractures and other bone injuries.

Main Products: The platform offers a range of standard radiology solutions. For example, BoneView is used to detect bone trauma lesions and has obtained FDA clearance for use in adults and children over the age of two in the United States; ChestView is used to detect pulmonary pathologies; Bone Measurement is used to automate musculoskeletal measurements; Bone Age is used to automate bone age estimation. All four solutions hold MDR Class IIa CE certification in Europe.

Platform Advantages: The relevance and exceptional performance of Gleamer's solutions have been recognized worldwide, with nine publications in highly regarded peer - reviewed journals. One of its papers won the 2022 Alexander Margulis Prize for the best paper on radiology awarded by the Radiological Society of North America (RSNA). In 2023, it was named the Eurominnies best vendor in radiology by Aunt Minnie Europe.

Application Scope: Its solutions are used in emergency rooms, battlefield medicine, and other scenarios, helping clinicians quickly identify bone trauma at the point of care. Currently, Gleamer's solutions have been widely adopted in the medical imaging industry, with 6,500 users in over 650 institutions across 24 countries.